Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Betamethasone dipropionate 0.5mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate 0.5mg/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate 0.5mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate 0.5% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate 0.05% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate 0.05% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate + clotrimazole 0.5mg/10mg lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Betamethasone dipropionate + clotrimazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Calcipotriene 0.005%/betamethasone 0.064% topical suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Augmented betamethasone dipropionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Betamethasone dipropionate |
Inferred relationship |
Some |
1 |